Recent formulation approaches to oral delivery of herbal medicines
- 169 Downloads
The well-known anticancer agent, paclitaxel, is a naturally occurring diterpenoid from Taxus brevifolia. It is an effective antineoplastic agent that has been widely used for the treatment of various cancers, including breast, ovarian, and lung cancers. One of the major limitations for the therapeutic use of herbal medicines is low solubility. Moreover, despite their potential efficacy, herbal medicinal products have been widely criticized due to a lack of standardization and poor apparent quality. In the case of herbal extracts, many compounds could be degraded in the highly acidic pH of the stomach. Other ingredients could be metabolized in the liver before reaching the systemic circulation. In addition, herbal extracts are often poorly compressible and very hygroscopic powders with poor powder flowability. As herbal drugs have much potential, several researchers are trying to develop novel drug delivery systems, such as solid dispersion, fast-dissolving tablets, sustained—and extended-release formulations, microparticles, microcapsules, nanoparticles, and mucoadhesive systems. This review provides an overview of existing pharmaceutical systems of herbal medicines and recent techniques to overcome the drawbacks of conventional formulations that result in reduced efficacy of herbal medicines.
KeywordsHerbal drug Extract Formulation Solid dispersion Tablet Granulation
This work was supported by research fund of Chungnam National University in 2016.
Compliance with ethical standards
Conflict of interest
All authors (JC Byeon, JB Ahn, WS Jang, SE Lee, JS Choi, JS Park) declare that they report no conflict of interest.
Research involving human participants and/or animals
This article does not contain any studies with human and animal subjects performed by any of the authors.
- Amol K, Pratibha P (2014) Novel drug delivery system in herbal’s. Int J Pharm Chem Biol Sci 4(4):910–930Google Scholar
- Bernatoniene J, Petkeviciute Z, Kalveniene Z, Masteikova R, Draksiene G, Muselik J, Bernatoniene R, Lazauskas R, Savickas A (2010) The investigation of phenolic compounds and technological properties of Leonurus, Crataegus and Ginkgo extracts. J Med Plants Res 4(10):925–931Google Scholar
- Bhattacharjee S, Chakraborty P, Jana M, Das R, Ganguly D (2016) Recent trends in granulation techniques: a technical review. World J Pharm Pharm Sci 5(9):434–454Google Scholar
- Chandira M, Jayakar B (2010) Formulation and evaluation of herbal tablets containing Ipomoea Digitate Linn. extract. Int J Pharm Sci Rev Res 3(1):101–110Google Scholar
- Koppukonda B, Venkatareddy K, Rao TV (2014) Advanced granulation technologies: a review. Ind J Res Pharm Biotech 2(6):1507–1511Google Scholar
- Marechal D, Yang WH, Hu YZ (2009) Sustained-release microgranules containing ginko biloba extract and the process for manufacturing these. US Patent No 7,569,236. Washington, DC. US Patent and Trademark OfficeGoogle Scholar
- Parakh SR, Gothoskar AV (2003) A review of mouth dissolving tablet technologies. Pharm Technol 27(11):92–100Google Scholar
- Prakash SS, Patra CN, Santanu C, Kumar PH, Patro VJ, Devi MV (2011) Studies on flowability, compressibility and in-vitro release of Terminalia Chebula fruit powder tablets. Iran J Pharm Res 10(3):393–401Google Scholar
- Rahul M, Bhagwat P, Patil SS, Shetkar MA, Chavan D (2014) A review on immediate release drug delivery systems. PharmaTutor 2(8):95–109Google Scholar
- Ray A, Gulati K (2010) Recent advances in herbal drug research and therapy. In: IK International. 2010, pp 23–25Google Scholar
- Soares LAL, González Ortega G, Petrovick PR, Schmidt PC (2005) Dry granulation and compression of spray-dried plant extracts. AAPS PharmSciTech 6(3):E359-E366Google Scholar
- Wichtl M (2004) Herbal drugs and phytopharmaceuticals: a handbook for practice on a scientific basis, 3rd edn. Medpharm Scientific Publishers, StuttgartGoogle Scholar
- World Health Organization (2007) WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residuesGoogle Scholar
- Xu TM, Cui MH, Xin Y, Gu LP, Jiang X, Su MM, Wang DD, Wang WJ (2008) Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin Med J 121(15):1394–1397Google Scholar